Safety and efficacy of percutaneous transabdominal and transesophageal decompression gastric catheters for palliation of malignant bowel obstruction.
Gastric catheters
Transabdominal
Transesophageal
Journal
Abdominal radiology (New York)
ISSN: 2366-0058
Titre abrégé: Abdom Radiol (NY)
Pays: United States
ID NLM: 101674571
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
received:
23
12
2020
accepted:
06
05
2021
revised:
27
04
2021
pubmed:
18
5
2021
medline:
7
9
2021
entrez:
17
5
2021
Statut:
ppublish
Résumé
To evaluate the safety and primary technical success rate of gastric decompression via percutaneous transabdominal gastrostomy (PTAG) or percutaneous transesophageal gastric (PTEG) catheter placement for management of malignant bowel obstruction (MBO). A secondary purpose was to evaluate the safety and success rate for PTAG catheter placement in patients with both MBO and ascites. A single-institution retrospective review of 385 patients who underwent attempted decompression gastric catheter placement from March 2013 to August 2018 was performed. Medical records and imaging studies were reviewed. A subgroup of patients with concomitant MBO and ascites were identified. The primary outcome measures were procedural technical success and procedural complications. 394 decompression gastrostomy catheters were attempted from 2013 to 2018, n = 353 PTAG and n = 41 PTEG. The success rate was 95.5% (n = 337 of 353) for PTAG and 97.6% (n = 40 of 41) for PTEG. There were 63 total complications involving 47 (13.9%) patients following PTAG and 13 total complications involving 9 (22.5%) patients following PTEG, P = 0.16. For the subgroup of patients with MBO and ascites, the success rate was 94.8% (n = 182 of 192 patients), and there were 20 complications involving 17 (12.9%) of 132 patients. Gastric decompression for patients with MBO via PTAG or PTEG catheter placement is associated with high success rates and low complications.
Identifiants
pubmed: 33999283
doi: 10.1007/s00261-021-03115-7
pii: 10.1007/s00261-021-03115-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4489-4498Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Tuca A, Guell E, Martinez-Losada E, Codorniu N (2012) Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution. Cancer Manag Res 4:159–169. https://doi.org/10.2147/CMAR.S29297
doi: 10.2147/CMAR.S29297
pubmed: 22904637
pmcid: 3421464
Mercadante S, Spoldi E, Caraceni A, Maddaloni S, Simonetti MT (1993) Octreotide in relieving gastrointestinal symptoms due to bowel obstruction. Palliat Med 7 (4):295–299. https://doi.org/10.1177/026921639300700406
doi: 10.1177/026921639300700406
pubmed: 7505187
Miller G, Boman J, Shrier I, Gordon PH (2000) Small-bowel obstruction secondary to malignant disease: an 11-year audit. Can J Surg 43 (5):353–358
pubmed: 11045093
pmcid: 3695141
Tuca A, Roca R, Sala C, Porta J, Serrano G, Gonzalez-Barboteo J, Gomez-Batiste X (2009) Efficacy of granisetron in the antiemetic control of nonsurgical intestinal obstruction in advanced cancer: a phase II clinical trial. J Pain Symptom Manage 37 (2):259–270. https://doi.org/10.1016/j.jpainsymman.2008.01.014
doi: 10.1016/j.jpainsymman.2008.01.014
pubmed: 18789638
Laval G, Arvieux C, Stefani L, Villard ML, Mestrallet JP, Cardin N (2006) Protocol for the treatment of malignant inoperable bowel obstruction: a prospective study of 80 cases at Grenoble University Hospital Center. J Pain Symptom Manage 31 (6):502–512. https://doi.org/10.1016/j.jpainsymman.2005.10.009
doi: 10.1016/j.jpainsymman.2005.10.009
pubmed: 16793490
Blair SL, Chu DZ, Schwarz RE (2001) Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer. Ann Surg Oncol 8 (8):632–637. https://doi.org/10.1007/s10434-001-0632-1
doi: 10.1007/s10434-001-0632-1
pubmed: 11569777
O'Connor OJ, Diver E, McDermott S, Covarrubias DA, Shelly MJ, Growdon W, Hahn PF, Mueller PR (2014) Palliative gastrostomy in the setting of voluminous ascites. J Palliat Med 17 (7):811–821. https://doi.org/10.1089/jpm.2013.0397
doi: 10.1089/jpm.2013.0397
pubmed: 24886044
Shaw C, Bassett RL, Fox PS, Schmeler KM, Overman MJ, Wallace MJ, Gupta S, Tam A (2013) Palliative venting gastrostomy in patients with malignant bowel obstruction and ascites. Ann Surg Oncol 20 (2):497–505. https://doi.org/10.1245/s10434-012-2643-5
doi: 10.1245/s10434-012-2643-5
pubmed: 22965572
Franke AJ, Iqbal A, Starr JS, Nair RM, George TJ, Jr. (2017) Management of Malignant Bowel Obstruction Associated With GI Cancers. J Oncol Pract 13 (7):426–434. https://doi.org/10.1200/JOP.2017.022210
doi: 10.1200/JOP.2017.022210
pubmed: 28697317
Ripamonti CI, Easson AM, Gerdes H (2008) Management of malignant bowel obstruction. Eur J Cancer 44 (8):1105–1115. https://doi.org/10.1016/j.ejca.2008.02.028
doi: 10.1016/j.ejca.2008.02.028
pubmed: 18359221
Meyer L, Pothuri B (2006) Decompressive percutaneous gastrostomy tube use in gynecologic malignancies. Curr Treat Options Oncol 7 (2):111–120. https://doi.org/10.1007/s11864-006-0046-1
doi: 10.1007/s11864-006-0046-1
pubmed: 16455022
Campagnutta E, Cannizzaro R (2000) Percutaneous endoscopic gastrostomy (PEG) in palliative treatment of non-operable intestinal obstruction due to gynecologic cancer: a review. Eur J Gynaecol Oncol 21 (4):397–402
pubmed: 11055494
Thampy S, Najran P, Mullan D, Laasch HU (2020) Safety and Efficacy of Venting Gastrostomy in Malignant Bowel Obstruction: A Systematic Review. J Palliat Care 35 (2):93–102. https://doi.org/10.1177/0825859719864915
doi: 10.1177/0825859719864915
pubmed: 31448682
Jacquet P, Jelinek JS, Steves MA, Sugarbaker PH (1993) Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 72 (5):1631–1636. https://doi.org/10.1002/1097-0142(19930901)72:5<1631::aid-cncr2820720523>3.0.co;2-i
doi: 10.1002/1097-0142(19930901)72:5<1631::aid-cncr2820720523>3.0.co;2-i
pubmed: 8348494
Tattersall MH, Butow PN, Clayton JM (2002) Insights from cancer patient communication research. Hematol Oncol Clin North Am 16 (3):731–743. https://doi.org/10.1016/s0889-8588(02)00022-9
doi: 10.1016/s0889-8588(02)00022-9
pubmed: 12170578
Hanks GW, Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Casas JR, Sawe J, Twycross RG, Ventafridda V, Expert Working Group of the Research Network of the European Association for Palliative C (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84 (5):587–593. https://doi.org/10.1054/bjoc.2001.1680
doi: 10.1054/bjoc.2001.1680
Tassinari D, Sartori S, Tamburini E, Scarpi E, Tombesi P, Santelmo C, Maltoni M (2009) Transdermal fentanyl as a front-line approach to moderate-severe pain: a meta-analysis of randomized clinical trials. J Palliat Care 25 (3):172–180
doi: 10.1177/082585970902500304
pubmed: 19824278
Pothuri B, Guirguis A, Gerdes H, Barakat RR, Chi DS (2004) The use of colorectal stents for palliation of large-bowel obstruction due to recurrent gynecologic cancer. Gynecol Oncol 95 (3):513–517. https://doi.org/10.1016/j.ygyno.2004.07.064
doi: 10.1016/j.ygyno.2004.07.064
pubmed: 15581955
Fainsinger RL, Spachynski K, Hanson J, Bruera E (1994) Symptom control in terminally ill patients with malignant bowel obstruction (MBO). J Pain Symptom Manage 9 (1):12–18. https://doi.org/10.1016/0885-3924(94)90141-4
doi: 10.1016/0885-3924(94)90141-4
pubmed: 7513332
Ventafridda V, Ripamonti C, Caraceni A, Spoldi E, Messina L, De Conno F (1990) The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori 76 (4):389–393
doi: 10.1177/030089169007600417
pubmed: 1697993
Selby D, Nolen A, Sittambalam C, Johansen K, Pugash R (2019) Percutaneous Transesophageal Gastrostomy (PTEG): A Safe and Well-Tolerated Procedure for Palliation of End-Stage Malignant Bowel Obstruction. J Pain Symptom Manage 58 (2):306–310. https://doi.org/10.1016/j.jpainsymman.2019.04.031
doi: 10.1016/j.jpainsymman.2019.04.031
pubmed: 31071424
Aramaki T, Arai Y, Takeuchi Y, Sone M, Sato R, Bekku E, Moriguchi M (2020) A randomized, controlled trial of the efficacy of percutaneous transesophageal gastro-tubing (PTEG) as palliative care for patients with malignant bowel obstruction: the JIVROSG0805 trial. Support Care Cancer 28 (6):2563–2569. https://doi.org/10.1007/s00520-019-05066-8
doi: 10.1007/s00520-019-05066-8
pubmed: 31494734
Udomsawaengsup S, Brethauer S, Kroh M, Chand B (2008) Percutaneous transesophageal gastrostomy (PTEG): a safe and effective technique for gastrointestinal decompression in malignant obstruction and massive ascites. Surg Endosc 22 (10):2314–2318. https://doi.org/10.1007/s00464-008-9984-y
doi: 10.1007/s00464-008-9984-y
pubmed: 18622539
Aramaki T, Arai Y, Inaba Y, Sato Y, Saito H, Sone M, Takeuchi Y (2013) Phase II study of percutaneous transesophageal gastrotubing for patients with malignant gastrointestinal obstruction; JIVROSG-0205. J Vasc Interv Radiol 24 (7):1011–1017. https://doi.org/10.1016/j.jvir.2013.04.005
doi: 10.1016/j.jvir.2013.04.005
pubmed: 23796088
Oshiro T, Saiki A, Suzuki J, Satoh A, Kitahara T, Kadoya K, Moriyama A, Ooshiro M, Nagashima M, Park Y, Okazumi S, Katoh R (2014) Percutaneous transesophageal gastro-tubing for management of gastric leakage after sleeve gastrectomy. Obes Surg 24 (9):1576–1580. https://doi.org/10.1007/s11695-014-1322-y
doi: 10.1007/s11695-014-1322-y
pubmed: 24917053
Murakami M, Nishino K, Takaoka Y, Murakami S, Mori K, Murakami B, Azuma M, Tanabe S, Kida M, Koizumi W (2013) Endoscopically assisted percutaneous transesophageal gastrotubing: a retrospective pilot study. Eur J Gastroenterol Hepatol 25 (8):989–995. https://doi.org/10.1097/MEG.0b013e3283614ae1
doi: 10.1097/MEG.0b013e3283614ae1
pubmed: 23652910
Singal AK, Dekovich AA, Tam AL, Wallace MJ (2010) Percutaneous transesophageal gastrostomy tube placement: an alternative to percutaneous endoscopic gastrostomy in patients with intra-abdominal metastasis. Gastrointest Endosc 71 (2):402–406. https://doi.org/10.1016/j.gie.2009.10.037
doi: 10.1016/j.gie.2009.10.037
pubmed: 20152318
Oishi H, Shindo H, Shirotani N, Kameoka S (2003) A nonsurgical technique to create an esophagostomy for difficult cases of percutaneous endoscopic gastrostomy. Surg Endosc 17 (8):1224–1227. https://doi.org/10.1007/s00464-002-8948-x
doi: 10.1007/s00464-002-8948-x
pubmed: 12739113
Mackey R, Chand B, Oishi H, Kameoka S, Ponsky JL (2005) Percutaneous transesophageal gastrostomy tube for decompression of malignant obstruction: report of the first case and our series in the US. J Am Coll Surg 201 (5):695–700. https://doi.org/10.1016/j.jamcollsurg.2005.05.036
doi: 10.1016/j.jamcollsurg.2005.05.036
pubmed: 16256911
Toh Yoon EW, Nishihara K (2017) Percutaneous transesophageal gastro-tubing (PTEG) as an alternative long-term tube feeding procedure when gastrostomy is not feasible. Therap Adv Gastroenterol 10 (12):911–917. https://doi.org/10.1177/1756283X17730810
doi: 10.1177/1756283X17730810
pubmed: 29204186
pmcid: 5703106
Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240 (2):205–213. https://doi.org/10.1097/01.sla.0000133083.54934.ae
doi: 10.1097/01.sla.0000133083.54934.ae
pubmed: 15273542
pmcid: 1360123
Burns KM, Huang SY Percutaneous Transesophageal Gastric Tubes: Indications, Technique, Safety, efficacy, and Management. Dig Dis Interv. https://doi.org/10.1055/s-0038-1639598
Litwin RJ, Chan JL, Huang SY Malignant Gastrointestinal Obstruction: Options for Decompression and Nutrition. Dig Dis Interv (4):311–322. https://doi.org/10.1055/s-0040-1718390